0001209191-22-001341.txt : 20220104 0001209191-22-001341.hdr.sgml : 20220104 20220104214235 ACCESSION NUMBER: 0001209191-22-001341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schall Thomas J. CENTRAL INDEX KEY: 0001423084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 22509230 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-01 0 0001340652 ChemoCentryx, Inc. CCXI 0001423084 Schall Thomas J. C/O CHEMOCENTRYX, INC. 835 INDUSTRIAL ROAD, SUITE 600 SAN CARLOS CA 94070 1 1 0 0 President and CEO Common Stock 2022-01-01 4 M 0 23334 0.00 A 2378150 D Common Stock 2022-01-01 4 M 0 34567 0.00 A 2412717 D Common Stock 2022-01-01 4 M 0 26333 0.00 A 2439050 D Common Stock 2022-01-01 4 F 0 45698 36.41 D 2393352 D Restricted Stock Units 2022-01-01 4 M 0 23334 D Common Stock 23334 0 D Restricted Stock Units 2022-01-01 4 M 0 34567 D Common Stock 34567 34567 D Restricted Stock Units 2022-01-01 4 M 0 26333 D Common Stock 26333 52667 D Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019. Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020. Shares were acquired upon vesting of restricted stock units awarded on February 25, 2021. Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation. Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date. The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date. The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date. /s/ Susan M. Kanaya, as Attorney-in-Fact 2022-01-04